Didronel

Active Ingredient(s): Etidronate
FDA Approved: * September 1, 1977
Pharm Company: * PROCTER AND GAMBLE
Category: Paget's Disease

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Didronel Overview

Etidronic acid, also known as etidronate, is a bisphosphonate used in detergents, water treatment, cosmetics and as a medication. It was patented in 1966 and approved for medical use in 1977.[1] Contents 1 Use 1.1 Medical 1.1.1 Chemical 2 Chelating agent and antioxidant 3 Pharmacology 4 Synthesis 5 References Use Medical Etidronic acid is a bisphosphonate used to strengthen bone, treat osteoporosis, and treat Paget's disease of bone. Bisphosphonates primarily ...

Read more Didronel Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Etidronic_acid

Recent Didronel Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Etidronate
  • Injection: 50mg/ml
  • Tablet: 200mg, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Etidronate or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA